CANF

Can-Fite BioPharma

13 hedge funds and large institutions have $472K invested in Can-Fite BioPharma in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$81.5K
2 +$14K
3 +$9K
4
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
+$2K

Top Sellers

1 -$169K
2 -$36K
3 -$23K
4
HF
HRT Financial
New York
-$15K
5
Osaic Holdings
Osaic Holdings
Arizona
-$1K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$377K
2
$37K
3
$15K
4
$14K
5
$9K
6
$7K
7
$7K
8
$2K
9
$2K
10
$1.36K
11
$661
12
$303
13
14
15
16
17